Founder, Chairman, and CEO of Shanghai Baiying Biotechnology Co., Ltd., holding a Master's degree in Bioengineering from East China University of Science and Technology and an EMBA degree from CEIBS. With two decades of expertise in antibody drug R&D, President Cha has amassed profound experience in genetic engineering research and management. In 2012, he founded Baiying Biotechnology, a R&D service enterprise specializing in antibody expression and antibody discovery, recognized as a National High-Tech Enterprise and a National-level Specialized and Novel Small Giant Enterprise.